Type 3procollagen peptide Procollagen III peptide, often referred to as PIIINP or P3NP, is a significant biomarker in the assessment of collagen turnover and tissue health. Specifically, it represents the amino-terminal peptide cleaved from type III procollagen during the synthesis and deposition of type III collagenProcollagen Type III N-Terminal Propeptide (PIIINP) Protein. This crucial extracellular matrix protein is abundant in connective tissues such as skin, blood vessels, and internal organs, playing a vital role in their structure and function. As a serum marker, procollagen III peptide offers a non-invasive window into processes like fibrosis, scar formation, and tissue repair.
The clinical utility of procollagen III peptide is most prominently recognized in its role as an indicator of hepatic fibrosis. In individuals undergoing long-term treatment with methotrexate, particularly those with psoriasis, monitoring PIIINP levels is advised to assess potential liver damage. This serologic marker can help track the progression or regression of fibrosis, potentially reducing the need for more invasive procedures like liver biopsies. Beyond liver health, elevated PIIINP levels have also been associated with other conditions involving fibrosis, including skeletal muscle and cardiac fibrosis, and may reflect repair processes following acute tissue damageProcollagen III peptide.
Collagen, the most abundant protein in the human body, is a family of structural proteins that form connective tissues. Type III collagen, characterized by its presence in reticular fibers, is a major component of dense and loose connective tissues. Procollagen is the precursor molecule synthesized within cells before being secreted and processed into mature collagen. During this maturation process, specific peptide extensions are cleaved from the procollagen molecule. The N-terminal propeptide of type III procollagen (PIIINP) is one such fragment that is released into the bloodstream.
The measurement of circulating PIIINP provides insights into the dynamic process of collagen synthesis and degradation. An increase in PIIINP levels can indicate heightened collagen production, often in response to tissue injury, inflammation, or disease processes that lead to fibrosis. Conversely, a decrease may suggest reduced collagen synthesis or successful intervention in fibrotic conditionsP3NP >8.1ug/L on 3 separate occasions in a 12 month periodrequires further investigation and assessment. (See BSR/BHPR guidelines).
The primary clinical application of procollagen III peptide testing revolves around monitoring fibrotic conditions, particularly in the liver.Procollagen - an overview | ScienceDirect Topics
* Hepatic Fibrosis Monitoring: For patients on methotrexate therapy, PIIINP serves as a valuable tool to detect and monitor hepatic fibrosis. Its ability to reflect scar formation in the liver makes it a useful surrogate marker for disease activity. Studies have explored its use in various liver diseases, including primary biliary cirrhosis and non-alcoholic steatohepatitis (NASH), where it has shown association with histological diagnoses of fibrosis.
* Scar Formation and Tissue Repair: PIIINP is also recognized as a marker of scar formationProcollagen type I C-peptide (PIP) has been extensively referenced in correlation studies between collagen levels and certain health disorders.. Transient elevations may be observed following acute tissue damage, necessitating follow-up measurements to distinguish between temporary repair responses and persistent fibrotic processesCirculating Procollagen Type III N-Terminal Peptide ... - PMC. Its role in reflecting repair processes has also been investigated in the context of myocardial infarctionProcollagen 3 Peptide. Code. PRCO. Sample Reqs. B. Turnaround. 5 days. Special instructions. No special instructions. Sample type guide..
* Connective Tissue Disorders: While less commonly cited than its role in fibrosis, defects in the gene encoding type III collagen (COL3A1) are linked to connective tissue disorders such as Ehlers-Danlos syndrome type 3.ELISA Human PIIINP (Pro-Collagen 3 N-Perminal ... Although PIIINP measurement is not a primary diagnostic tool for these conditions, it underscores the fundamental importance of type III collagen in maintaining tissue integrity.
Interpreting PIIINP test results requires careful consideration of the clinical context.Amino-terminal peptide of type III procollagen (PIIINP)is a peptide that released from the precursor peptide, during the synthesis and deposition of type III ... Normal ranges for PIIINP can vary depending on the laboratory and assay used, but generally, elevated levels suggest increased collagen turnover and potential fibrotic activity.PIIINP (P3NP; Procollagen 3 N-terminal peptide) For instance, a threshold of P3NP >8.1 ug/L on multiple occasions within a year might warrant further investigation and assessment according to specific clinical guidelines.
The sensitivity of assays, such as ELISA kits for human PIIINP, is crucial for accurate detection, with detection ranges and sample volumes being important technical specifications.Procollagen III N-Terminal Propeptide (PIIINP) (N-Term) ... While PIIINP is a valuable research tool for fibrosis research and can be determined in blood, it's important to note that some commercially available PIIINP products are designated for research use only and not for diagnostic or therapeutic purposes.
Ongoing research continues to explore the full potential of procollagen III peptide as a biomarkerSensitivity, 14.06 pg/mL. Detection Range, 23.44-1500 pg/mL. Sample Volume, 100 μL. Total Assay Time, 3 h 30 min. Reactivity, Human.. Investigations into its correlation with other markers, such as serum type I collagen and aminotransferases, aim to refine diagnostic and prognostic capabilitiesProcollagen III N-terminal peptide. Furthermore, the development of more sensitive and specific assays, along with a deeper understanding of the factors influencing PIIINP levels, will enhance its utility in managing a range of fibrotic and connective tissue-related diseases.Procollagen Type III N-Terminal Propeptide (PIIINP) Protein The ability to non-invasively monitor tissue remodeling processes through biomarkers like PIIINP holds significant promise for personalized medicine and improved patient outcomes.
Join the newsletter to receive news, updates, new products and freebies in your inbox.